Literature DB >> 2171549

Malignant transformation of human endometrial stromal cells by transfection of c-myc: effects of pRSVneo cotransfection and treatment with MNNG.

B D Lyn-Cook1, G P Siegal, D G Kaufman.   

Abstract

Stromal cells isolated from normal human endometrium were cotransfected in primary culture with pSVc-myc, a plasmid containing a truncated c-myc gene regulated by simian virus 40 promoter, and pRSV neo, a plasmid containing a neomycin resistance gene regulated by Rous sarcoma virus (RSV) promoter. These cells demonstrated properties of transformed cells in vitro, including altered morphology, focus formation, anchorage-independent growth, chromosomal alterations, and tumor formation in athymic mice. When these cells were treated subsequently with a direct-acting carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine, they demonstrated higher colony-forming efficiency in soft agar and reduced tumor latency. Cells transfected with pRSV neo alone exhibited some properties associated with neoplastic transformation, including altered morphology and formation of colonies in soft agar. It is presumed that in normal cells transfected with pRSV neo, RSV long terminal repeats activated cellular genes that normally regulate growth of human endometrial stromal cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171549     DOI: 10.1159/000163576

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  2 in total

1.  Cyclin E Overexpression in Human Mammary Epithelial Cells Promotes Epithelial Cancer-Specific Copy Number Alterations.

Authors:  Servando Giraldez; Pablo Tamayo; Nathan Wineinger; William Kim; Steven I Reed
Journal:  iScience       Date:  2019-08-27

2.  JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.

Authors:  Haifeng Qiu; Jing Li; Leslie H Clark; Amanda L Jackson; Lu Zhang; Hui Guo; Joshua E Kilgore; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Oncotarget       Date:  2016-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.